Cargando…

Prevention and management of hyperkalemia in patients treated with renin–angiotensin–aldosterone system inhibitors

Detalles Bibliográficos
Autores principales: Weinstein, Jordan, Girard, Louis-Philippe, Lepage, Serge, McKelvie, Robert S., Tennankore, Karthik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: CMA Joule Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8648362/
https://www.ncbi.nlm.nih.gov/pubmed/34872955
http://dx.doi.org/10.1503/cmaj.210831
_version_ 1784610786411282432
author Weinstein, Jordan
Girard, Louis-Philippe
Lepage, Serge
McKelvie, Robert S.
Tennankore, Karthik
author_facet Weinstein, Jordan
Girard, Louis-Philippe
Lepage, Serge
McKelvie, Robert S.
Tennankore, Karthik
author_sort Weinstein, Jordan
collection PubMed
description
format Online
Article
Text
id pubmed-8648362
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher CMA Joule Inc.
record_format MEDLINE/PubMed
spelling pubmed-86483622021-12-12 Prevention and management of hyperkalemia in patients treated with renin–angiotensin–aldosterone system inhibitors Weinstein, Jordan Girard, Louis-Philippe Lepage, Serge McKelvie, Robert S. Tennankore, Karthik CMAJ Review CMA Joule Inc. 2021-12-06 /pmc/articles/PMC8648362/ /pubmed/34872955 http://dx.doi.org/10.1503/cmaj.210831 Text en © 2021 CMA Joule Inc. or its licensors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY-NC-ND 4.0) licence, which permits use, distribution and reproduction in any medium, provided that the original publication is properly cited, the use is noncommercial (i.e., research or educational use), and no modifications or adaptations are made. See: https://creativecommons.org/licenses/by-nc-nd/4.0/
spellingShingle Review
Weinstein, Jordan
Girard, Louis-Philippe
Lepage, Serge
McKelvie, Robert S.
Tennankore, Karthik
Prevention and management of hyperkalemia in patients treated with renin–angiotensin–aldosterone system inhibitors
title Prevention and management of hyperkalemia in patients treated with renin–angiotensin–aldosterone system inhibitors
title_full Prevention and management of hyperkalemia in patients treated with renin–angiotensin–aldosterone system inhibitors
title_fullStr Prevention and management of hyperkalemia in patients treated with renin–angiotensin–aldosterone system inhibitors
title_full_unstemmed Prevention and management of hyperkalemia in patients treated with renin–angiotensin–aldosterone system inhibitors
title_short Prevention and management of hyperkalemia in patients treated with renin–angiotensin–aldosterone system inhibitors
title_sort prevention and management of hyperkalemia in patients treated with renin–angiotensin–aldosterone system inhibitors
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8648362/
https://www.ncbi.nlm.nih.gov/pubmed/34872955
http://dx.doi.org/10.1503/cmaj.210831
work_keys_str_mv AT weinsteinjordan preventionandmanagementofhyperkalemiainpatientstreatedwithreninangiotensinaldosteronesysteminhibitors
AT girardlouisphilippe preventionandmanagementofhyperkalemiainpatientstreatedwithreninangiotensinaldosteronesysteminhibitors
AT lepageserge preventionandmanagementofhyperkalemiainpatientstreatedwithreninangiotensinaldosteronesysteminhibitors
AT mckelvieroberts preventionandmanagementofhyperkalemiainpatientstreatedwithreninangiotensinaldosteronesysteminhibitors
AT tennankorekarthik preventionandmanagementofhyperkalemiainpatientstreatedwithreninangiotensinaldosteronesysteminhibitors